Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a biopharmaceutical company developing and commercializing innovative cardiovascular medicines to benefit people living with certain heart conditions.

XYRA gets US patent protecting use of dose adjusted budiodarone to treat AF, with monitoring to correspondingly reduce/delay risk of stroke and/or congestive heart failure: Los Al ...

Reciting a poem or play, by synchronizing breath and heart rate to verse, has been found to reduce stress and relax the mind.

Recently, Reddit user Mr_Creep_Creepy64 asked the question, "Redditors, what’s the most terrifying thing that has ever woken ...

The new OPPO Watch S sits somewhere between two extremes. It’s a smartwatch with a sleek design, great at tracking what I want, and have a good battery life.  ...

A doctor recently shared a striking case from the emergency room that has sparked widespread discussion online. The story ...

The situation is dire. Donald Trump’s Big Ugly Bill gutted Medicare and Medicaid. This pre-fascist madman highjacked our taxpayer money and gave it to his rich friends.

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

Saturday, March 14 Evan Tatum starts the afternoon with a set at the Warwick Valley Winery, Distillery & Orchard, 114 Little ...

A story from a hospital emergency room is going viral online. It shows how even one small tablet can sometimes change the way ...

The FDA has granted Fast Track designation to AFTX-201 for the treatment of BAG3-associated dilated cardiomyopathy.

Company launched TONMYA, approved by the FDA as a treatment for fibromyalgia, in November 2025 In post hoc analysis of the pivotal RESILIENT study, TONMYA produced rapid pain relief as early as Day 2 ...